1. Home
  2. JOE vs NAMS Comparison

JOE vs NAMS Comparison

Compare JOE & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo St. Joe Company (The)

JOE

St. Joe Company (The)

N/A

Current Price

$67.37

Market Cap

3.4B

Sector

Real Estate

ML Signal

N/A

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

N/A

Current Price

$32.14

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JOE
NAMS
Founded
1936
2019
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
JOE
NAMS
Price
$67.37
$32.14
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$47.38
AVG Volume (30 Days)
182.7K
661.5K
Earning Date
02-25-2026
02-25-2026
Dividend Yield
0.94%
N/A
EPS Growth
53.79
N/A
EPS
1.80
N/A
Revenue
$488,689,000.00
$35,243,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.46
P/E Ratio
$37.71
N/A
Revenue Growth
26.89
4.91
52 Week Low
$40.19
$14.06
52 Week High
$68.48
$42.00

Technical Indicators

Market Signals
Indicator
JOE
NAMS
Relative Strength Index (RSI) 69.64 49.87
Support Level $64.42 $31.77
Resistance Level $67.35 $33.80
Average True Range (ATR) 1.60 1.42
MACD 0.19 0.16
Stochastic Oscillator 99.46 62.87

Price Performance

Historical Comparison
JOE
NAMS

About JOE St. Joe Company (The)

The St. Joe Co is a real estate development, asset management, and operating company and it has three operating segments; the Residential segment plans and develops residential communities and sells homesites to homebuilders or retail consumers, the Hospitality segment that derives maximum revenue, features a private membership club, hotel operations, food and beverage operations, golf courses, beach clubs, retail outlets, gulf-front vacation rentals, management services, marinas, and other entertainment assets, and Commercial segment include leasing of commercial property, multi-family, senior living, self-storage, and other assets and it also oversees the planning, development, entitlement, management, and sale of commercial and rural land holdings.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Share on Social Networks: